---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-296047"
form_type: "8-K"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:56:31.138761+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Wave Life Sciences updates corporate presentation; no specific material changes disclosed

## Summary
- Company furnished an updated corporate presentation dated December 15, 2023 as Exhibit 99.1.
- Presentation is available on the investor section of Wave Life Sciences' website.
- Filing contains no new financial or operational metrics, guidance, or business developments.
- No specific updates on pipeline, partnerships, or regulatory milestones were provided.

## SEC filing metadata
- accession: 0001193125-23-296047
- form_type: 8-K
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312523296047/0001193125-23-296047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312523296047/d576717d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-296047
- JSON: https://secwatch.observer/filing/0001193125-23-296047.json
- Plain text: https://secwatch.observer/filing/0001193125-23-296047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.